Abstract

Background: Periventricular white-matter (WM) injury is a prominent feature of brain injury in preterm infants. Thyroxin (T4) treatment reduces the severity of hypoxic-ischemic (HI)-mediated WM injury in the immature brain. This study aimed to delineate molecular events underlying T4 protection following periventricular WM injury in HI rats. Methods: Right common-carotid-artery ligation, followed by hypoxia, was performed on seven-day-old rat pups. The HI pups were injected with saline, or 0.2 or 1 mg/kg of T4 at 48–96 h postoperatively. Cortex and periventricular WM were dissected for real-time (RT)-quantitative polymerase chain reactions (PCRs), immunoblotting, and for immunofluorescence analysis of neurotrophins, myelin, oligodendrocyte precursors, and neointimal. Results: T4 significantly mitigated hypomyelination and oligodendrocyte death in HI pups, whereas angiogenesis of periventricular WM, observed using antiendothelium cell antibody (RECA-1) immunofluorescence and vascular endothelium growth factor (VEGF) immunoblotting, was not affected. T4 also increased the brain-derived neurotrophic factors (BDNFs), but not the nerve growth factor (NGF) expression of injured periventricular WM. However, phosphorylated extracellular signal regulated kinase (p-ERK) and phosphorylated cyclic adenosine monophosphate response element-binding protein (p-CREB) concentrations, but not the BDNF downstream pathway kinases, p38, c-Jun amino-terminal kinase (c-JNK), or Akt, were reduced in periventricular WM with T4 treatment. Notably, T4 administration significantly increased BDNF and phosphorylated CREB in the overlying cortex of the HI-induced injured cortex. Conclusion: Our findings reveal that T4 reversed BNDF signaling to attenuate HI-induced WM injury by activating ERK and CREB pathways in the cortex, but not directly in periventricular WM. This study offers molecular insight into the neuroprotective actions of T4 in HI-mediated WM injury in the immature brain.

Highlights

  • Periventricular white-matter (WM) injury is a major cause of brain injury, and underlies neuromotor abnormalities in preterm infants [1]

  • We previously demonstrated that thyroid hormone (TH) rescued HI-induced WM injury in the immature brain via upregulating brain-derived neurotrophic factors (BDNFs) in periventricular WM [9]

  • WM displayed weak myelin basic-protein (MBP) immunostaining in the HI compared with the sham group (Figure 1A), with HI significantly reducing MBP-immunostaining intensity (p < 0.01, Figure 1C)

Read more

Summary

Introduction

Periventricular white-matter (WM) injury is a major cause of brain injury, and underlies neuromotor abnormalities in preterm infants [1]. There is increasing clinical evidence and laboratory animal studies that reveal that oligodendrocyte lineage is most vulnerable to HI injury in preterm infants [1,4]. Pre-OLs are more likely in HI-mediated dysfunction than mature oligodendrocytes, indicating that early intervention may protect pre-OL damage during HI, reducing the severity of WM injury in the immature brain. Thyroxin (T4) treatment reduces the severity of hypoxic-ischemic (HI)-mediated WM injury in the immature brain. Results: T4 significantly mitigated hypomyelination and oligodendrocyte death in HI pups, whereas angiogenesis of periventricular WM, observed using antiendothelium cell antibody (RECA-1) immunofluorescence and vascular endothelium growth factor (VEGF) immunoblotting, was not affected. This study offers molecular insight into the neuroprotective actions of T4 in HI-mediated WM injury in the immature brain

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call